Encouraging responsible reporting in gene therapy: raising Oxford BioMedica’s profile

As part of its ongoing PR support for Oxford BioMedica, Northbank identified an opportunity to raise the Company’s profile around a recent Government Genetics White Paper. Following the considerable interest this created with journalists, Northbank organised a successful media briefing on gene therapy jointly with the Science Media Centre.

More than 15 science journalists from the national papers attended the briefing, and the event provided an excellent opportunity to raise the profile of Oxford BioMedica. The briefing resulted in significant coverage in the Independent (the lead story on page 2 of the paper, repeated in the tabloid issue), The Times, the Daily Telegraph, the Daily Mail, and Chemistry in Britain. Clive Cookson, the science editor of the Financial Times who attended the briefing, also followed up with a feature on gene therapy in the FT biotechnology survey published on 11 November.

Commenting on the gene therapy briefing, Katja Stout, Associate Director in charge of the Oxford BioMedica account, said, “We are delighted with the high levels of interest generated among science journalists and the subsequent quality press coverage. Oxford BioMedica is a leader in the area of gene-based medicines, and it is important to the Company that this field is portrayed in a positive light.”

View case study

back to news

© 2007 College Hill Associates | Registered in England No 1036926 / VAT No 245666930 | Legal